Skandinaviska Enskilda Banken AB publ Purchases 4,500 Shares of UiPath Inc. (NYSE:PATH)

Skandinaviska Enskilda Banken AB publ boosted its position in shares of UiPath Inc. (NYSE:PATH) by 3.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 154,036 shares of the healthcare company’s stock after acquiring an additional 4,500 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in UiPath were worth $1,953,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. ORG Partners LLC raised its stake in UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after acquiring an additional 1,112 shares during the period. Lindbrook Capital LLC raised its position in shares of UiPath by 46.0% in the first quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock valued at $46,000 after purchasing an additional 639 shares during the period. GAMMA Investing LLC lifted its stake in shares of UiPath by 40.2% during the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock worth $50,000 after buying an additional 632 shares during the last quarter. Hantz Financial Services Inc. acquired a new position in UiPath in the 2nd quarter valued at about $28,000. Finally, Benjamin F. Edwards & Company Inc. raised its holdings in UiPath by 122.5% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 2,556 shares of the healthcare company’s stock valued at $58,000 after acquiring an additional 1,407 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on PATH shares. Truist Financial reaffirmed a “hold” rating and issued a $14.00 target price (down previously from $32.00) on shares of UiPath in a research report on Thursday, May 30th. BMO Capital Markets increased their price objective on UiPath from $14.00 to $15.00 and gave the stock a “market perform” rating in a research report on Friday, September 6th. Canaccord Genuity Group reduced their target price on shares of UiPath from $30.00 to $19.00 and set a “buy” rating for the company in a research report on Friday, May 31st. TD Cowen decreased their price target on shares of UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, September 6th. Finally, Barclays lifted their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Friday, September 6th. Sixteen analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $17.71.

UiPath Price Performance

NYSE PATH opened at $12.91 on Tuesday. The company has a fifty day moving average price of $12.13 and a 200-day moving average price of $15.76. The firm has a market cap of $7.39 billion, a price-to-earnings ratio of -80.69 and a beta of 0.87. UiPath Inc. has a 1 year low of $10.37 and a 1 year high of $27.87.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. The business had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.09) EPS. On average, research analysts anticipate that UiPath Inc. will post -0.23 EPS for the current fiscal year.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 47,671 shares of the stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares in the company, valued at approximately $10,258,498.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 22.37% of the stock is currently owned by company insiders.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.